The Politics and History of AIDS Treatment in Brazil (eBook)

(Autor)

eBook Download: PDF
2009 | 2009
XXIII, 186 Seiten
Springer New York (Verlag)
978-0-387-09618-6 (ISBN)

Lese- und Medienproben

The Politics and History of AIDS Treatment in Brazil - Amy Nunn
Systemvoraussetzungen
96,29 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Brazil's public policy response to the AIDS epidemic preceded those of many developing countries. During my tenure as President, in 1996, Brazil adopted a law guaranteeing free and universal access to AIDS treatment for all people living with HIV/AIDS. Brazil became the first developing country to provide publicly-financed AIDS treatment for all people living with HIV/AIDS. We now have one of the world's most successful AIDS programs that is considered a model for other dev- oping countries. Today, 185,000 people receive life-saving AIDS cocktails in Brazil, and thousands of lives have been saved. But this was not an easy battle. There were many challenges along the way. Twenty years ago, Brazil's achie- ments today might have seemed impossible. During the 1980s, in Brazil, as elsewhere, there was overwhelming stigma associated with AIDS; people living with HIV often lost their jobs and died quickly before the advent of life-saving antiretroviral drugs. Brazil's AIDS movement was extraordinarily important in promoting progressive AIDS policies; associations of people living with HIV were the first to denounce pervasive AIDS-related discri- nation and called public attention to the importance of AIDS. Activists protested in the streets for over a decade, engaged the media, and framed AIDS as a human rights issue.

Dr. Amy Nunn is a postdoctoral research fellow in the Division of Infectious Diseases at Brown Medical School where she conducts research on HIV testing, HIV risk behaviors, and how to best link people living with HIV/AIDS to treatment and care services. A social scientist by training, Dr. Nunn has worked in several countries where she conducted domestic and international research on a variety of health policy topics including HIV/AIDS, patient safety, access to reproductive health services, and family planning. Her current HIV/AIDS research is financed by the National Institutes of Health and the Brown University Center for AIDS Research. She has received research grants from Harvard University, the US Department of Defense, and the US Department of Education. Dr. Nunn holds masters and doctoral degrees from the Harvard School of Public Health and is a Fulbright Scholar.


Brazil's public policy response to the AIDS epidemic preceded those of many developing countries. During my tenure as President, in 1996, Brazil adopted a law guaranteeing free and universal access to AIDS treatment for all people living with HIV/AIDS. Brazil became the first developing country to provide publicly-financed AIDS treatment for all people living with HIV/AIDS. We now have one of the world's most successful AIDS programs that is considered a model for other dev- oping countries. Today, 185,000 people receive life-saving AIDS cocktails in Brazil, and thousands of lives have been saved. But this was not an easy battle. There were many challenges along the way. Twenty years ago, Brazil's achie- ments today might have seemed impossible. During the 1980s, in Brazil, as elsewhere, there was overwhelming stigma associated with AIDS; people living with HIV often lost their jobs and died quickly before the advent of life-saving antiretroviral drugs. Brazil's AIDS movement was extraordinarily important in promoting progressive AIDS policies; associations of people living with HIV were the first to denounce pervasive AIDS-related discri- nation and called public attention to the importance of AIDS. Activists protested in the streets for over a decade, engaged the media, and framed AIDS as a human rights issue.

Dr. Amy Nunn is a postdoctoral research fellow in the Division of Infectious Diseases at Brown Medical School where she conducts research on HIV testing, HIV risk behaviors, and how to best link people living with HIV/AIDS to treatment and care services. A social scientist by training, Dr. Nunn has worked in several countries where she conducted domestic and international research on a variety of health policy topics including HIV/AIDS, patient safety, access to reproductive health services, and family planning. Her current HIV/AIDS research is financed by the National Institutes of Health and the Brown University Center for AIDS Research. She has received research grants from Harvard University, the US Department of Defense, and the US Department of Education. Dr. Nunn holds masters and doctoral degrees from the Harvard School of Public Health and is a Fulbright Scholar.

Introduction 19
Ezio’s Story 19
AIDS in Brazil 20
The AIDS Crisis and Democratization in Brazil 28
Brazil 28
Building Democracy in Post-Authoritarian Brazil 32
The State and Public Health 35
AIDS in Brazil 37
Brazil’s AIDS Program 39
Democratization and Institutional Precursors to AIDS Treatment in Brazil 47
Sanitarista Health Reform Objectives 47
Reformers Working Within the State 49
Brazil’s First Public and Civil Society Partnerships for AIDS 50
The Evolution of Sanitarista Strategiesin Postauthoritarian Brazil 52
AIDS Activism in Rio de Janeiro State 54
The 1988 Constitution and the Right to Health 56
Development of Brazil’s First AIDS Treatment Institutions in a New Democracy 61
Social Movements Infiltrate the State 61
Early Federal AIDS Programs 62
The Genesis of the AIDS Movement 65
Committing to Treat AIDS 70
National AIDS Program Partnerships with the AIDS Movement 77
Mounting Pressure for AIDS Treatment and Brazil’s First World Bank Loans for AIDS 80
Legislative Reforms and AIDS Treatment in the 1990s 91
Public/Private Partnerships to Develop AZT 92
Public Production of AZT 94
Industrial Property Law 9.279 96
Fernando Henrique Cardoso’s 1994 Presidential Victory 96
Brazil and the World Trade Organization 98
Law 9.279’s Implications for AIDS Treatment 100
Political Action and Chronic Shortages in Drug Supplies for AIDS Treatment 101
Sarney’s Law: Law 9.313 103
Cumulative Impacts of the Industrial Property Law and Sarney’s Law 107
Development of Brazil’s Contemporary AIDS Treatment Institutions 111
Sanitarista Leadership in the National AIDS Program Bureaucracy 111
World Bank AIDS II Loans 116
AIDS II and the AIDS Movement 118
The Evolving Political Context of the Late 1990s 120
The 1998 Drug Policy Reforms 124
A Decisive Step: José Serra and the Domestic Production of ARVs 125
Brazil’s Contributions to Global Essential Medicines Institutions 135
Growing Political Momentun for Affordable Access to Medicines 135
The Global AIDS Treatment Movement 136
Global Launch of Generic ARVs 137
The Global Fund to Fight AIDS, Tuberculosis, and Malaria 139
José Serra’s Essential Medicines Strategy 139
Brazil’s Efforts to Change Global Essential Medicines Institutions in 2000 142
Brazil’s Contributions to Global Essential Medicines Institutions in 2001 143
Intellectual Property and Human Rights Resolution 147
US Drops WTO Dispute 150
The UN General Assembly Special Session on HIV/AIDS 151
World Trade Organization 152
Price Declines for ARVs in Brazil 155
The Symbiotic Relationship between José Serra and the AIDS Movement 156
Brazil’s Contributions to Essential Medicines Institutions from 2002 to 2006 158
Brazil’s Enduring Legacies 159
Conclusion 164
Building Brazil’s AIDS Treatment Institutions 165
Costs and Compulsory Licenses 167
Looking Ahead 171
Global Impact 173
Implications for Other Countries 174
Study Strengths and Limitations 178
The Brazilian Model 180

Erscheint lt. Verlag 15.2.2009
Zusatzinfo XXIII, 186 p.
Verlagsort New York
Sprache englisch
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie Krankheiten / Heilverfahren
Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete
Studium Querschnittsbereiche Infektiologie / Immunologie
Sozialwissenschaften Politik / Verwaltung
Schlagworte AIDS • Brazil • developing world • Epidemic • health policy • health reform • HIV • HIV/Aids • Infectious Diseases • Latin America • Public Health • School of Public Health • Tod • universal access to care
ISBN-10 0-387-09618-3 / 0387096183
ISBN-13 978-0-387-09618-6 / 9780387096186
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 2,6 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

von Hans-Reinhard Brodt; Achim Hörauf; Michael Kresken …

eBook Download (2023)
Thieme (Verlag)
164,99
Mit den neuen Preisen vom 1.10.2023

von Peter M. Hermanns; Enrico Schwartz; Katharina von Pannwitz

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
59,99